Tc-99m pyrophosphate scintigraphy for cardiac amyloidosis: concordance between planar and SPECT/CT imaging

被引:0
作者
Nazim Coskun
M. Oguz Kartal
A. Sinem Erdogan
Omac Tufekcioglu
Elif Ozdemir
机构
[1] Ankara City Hospital,Department of Nuclear Medicine
[2] Ankara City Hospital,Department of Cardiology
[3] Ankara Yildirim Beyazit University,Department of Nuclear Medicine
来源
The International Journal of Cardiovascular Imaging | 2022年 / 38卷
关键词
Cardiac amyloidosis; Radionuclide imaging; SPECT/CT;
D O I
暂无
中图分类号
学科分类号
摘要
The imaging protocol and the optimal cut-off points for quantitative assessment of technetium-99m pyrophosphate (Tc-99m PYP) cardiac amyloidosis scintigraphy remain controversial. The aim of this study was to evaluate the concordance between planar and SPECT images, and to investigate the contribution of SPECT/CT to diagnostic precision. All patients referred to our department for Tc-99m PYP cardiac imaging between April 2019 and April 2022 were included in the study. Heart-to-contralateral lung (H/CL) ratios were calculated from anterior planar images at both 1- and 3 h, and visual grading was done in SPECT/CT images at both time points. A total of 141 patients were included in the study (median age 59 years, 54% female). There was a strong positive correlation between H/CL ratios calculated at 1- and 3 h (Pearson’s ρ = 0.842, p < 0.001). The highest level of concordance between planar and SPECT/CT images was achieved at a H/CL cut-off point of 1.5 for 1-h images, and 1.4 for 3-h images. SPECT/CT imaging contributed to diagnostic precision in both 1- and 3-h images by reducing the rate of equivocal results from 83% (n = 117) to 25% (n = 35), and from 77% (n = 108) to 27% (n = 38), respectively. Our findings have three implications: (1) planar imaging at both 1- and 3 h could be redundant, (2) a lower H/CL cut-off point for 3-h planar images could improve concordance between planar and SPECT imaging, and (3) SPECT/CT in both 1- and 3 h could improve the diagnostic precision by offering markedly reduced equivocal results.
引用
收藏
页码:2081 / 2088
页数:7
相关论文
共 77 条
[1]  
Dorbala S(2021)ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging Circ Cardiovasc Imaging 14 1945-1955
[2]  
Ando Y(2018)Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis Eur J Nucl Med Mol Imaging 45 2404-2412
[3]  
Bokhari S(2016)Nonbiopsy diagnosis of cardiac transthyretin amyloidosis Circulation 133 1769-1774
[4]  
Dispenzieri A(2021)Addendum to ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging J Nucl Cardiol 28 e006075-1084
[5]  
Falk RH(2019)Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis Circ Heart Fail 12 1076-347
[6]  
Ferrari VA(2005)Noninvasive etiologic diagnosis of cardiac amyloidosis using J Am Coll Cardiol 46 337-220
[7]  
Treglia G(2017)Tc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy J Intern Med 281 210-1350
[8]  
Glaudemans A(2015)One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition Amyloid 22 1344-506
[9]  
Bertagna F(2017)Usefulness of Eur Heart J Cardiovasc Imaging 18 503-1815
[10]  
Hazenberg BPC(2021)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis J Nucl Cardiol 28 1808-889